
    
      Prospective, multicenter, non-randomized study designed to enroll up to 60 subjects to
      evaluate the safety and effectiveness of the cobalt-chromium sirolimus eluting coronary stent
      ALEX in a real-world setting of percutaneous coronary interventions in patients with coronary
      heart disease.
    
  